ZeaVision patented Zeaxanthin to help fight Age-Related Macular Degeneration
ST. LOUIS, Sept. 17, 2010 — ZeaVision, LLC launched a unique online campaign to create awareness about Age-Related Macular Degeneration for AMD Awareness Week, September 18-26.
Directed toward consumers as well as EyeCare Professionals, the company has issued the "AMD Challenge" at . At the website, visitors play a scratch-off game that provides education about AMD, while providing the chance to win a free bottle of EyePromise® professional supplements.
Chris Barber, President of ZeaVision, explains, "As the company that patented Zeaxanthin for rebuilding macular pigment in the eye, we feel it is our duty and mission to create awareness around this debilitating disease. People can test their knowledge about macular degeneration, and learn more about the effects and risk factors in an interactive way, by taking the AMD Challenge at "
Age-related macular degeneration (AMD) affects approximately 30 million people worldwide and is the leading cause of blindness over age 50. AMD affects the macula – the middle part of the retina responsible for central vision, is irreversible, and incurable. The disease is growing at an alarming rate, and education is the first step in fighting AMD. Everyone is encouraged to learn more about the risk factors at . For more information on AMD, visit the company's website at http://www.zeavision.com
ZeaVision and its founder have nearly 20 years of research and development and hold patents on Zeaxanthin, a natural nutrient derived from paprika shown to increase macular pigment levels. The company also offers a state-of-the art testing device as part of its comprehensive Eye-Q Intelligent AMD Risk Management program. The testing device, QuantifEye®, measures macular pigment density, and allows EyeCare Professionals to measure, manage, monitor, and maintain AMD risk factors for patients.
ZeaVision logo:
http://www.ereleases.com/pic/ZeaVision-logo.jpg
EyePromise logo:
http://www.ereleases.com/pic/EyePromise-logo.png
About ZeaVision
ZeaVision is Passionate About Prevention and develops products for patients and EyeCare Professionals for managing Age-Related Macular Degeneration (AMD) risk factors, and to maintain healthy vision. The company holds patents on Zeaxanthin, which is prominently featured in its EyePromise® Supplements. ZeaVision also markets QuantifEye®, a testing device that measures macular pigment, as well as Eye-Q, the company's comprehensive AMD Risk Management program. For more information, please visit http://www.zeavision.com or call 866-833-2800.
ZeaVision, EyePromise, QuantifEye, and Eye-Q the respective logos are registered trademarks of ZeaVision, LLC. All other trademarks herein are properties of their respective owners. All rights reserved.
Contact:
Betsy Ley
Director Marketing and Customer Service
ZeaVision
(866) 833-2800
Email
# # #